Part Details | CIMETIDINE HYDROCHLORIDE ORAL SOLUTION
6505-01-119-0616
Alternate Parts: NDC00472051408, NDC00472-0514-08, NDC60505035302, NDC60505-0353-02, NDC00108501448, NDC00108-5014-48, TAGAMET LIQUID, NDC50383005008, NDC50383-0050-08, NDC00093050687, NDC00093-0506-87, NDC60432000708, NDC60432-0007-08, NDC00121064908, NDC00121-0649-08, 6505-01-119-0616, 01-119-0616, 6505011190616, 011190616
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | SEP 16, 1981 | 01-119-0616 | 35891 ( CIMETIDINE HYDROCHLORIDE ORAL SOLUTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-119-0616
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00472-0514-08 | 1SFA8 | ALPHARMA US PHARMACEUTICALS DIVISIONDBA ALPHARMA |
| NDC60505-0353-02 | 1VZL6 | FALCON PHARMACEUTICALS LTD |
| NDC00108-5014-48 | 93544 | GLAXOSMITHKLINE HOLDINGS AMERICASINC. |
| TAGAMET LIQUID | 93544 | GLAXOSMITHKLINE HOLDINGS AMERICASINC. |
| NDC50383-0050-08 | 8J658 | HI-TECH PHARMACAL CO., INC.DBA HEALTH CARE PRODUCTS |
| NDC00093-0506-87 | 80608 | LEMMON CO |
| NDC60432-0007-08 | 00QD1 | MORTON GROVE PHARMACEUTICALS INC. |
| NDC00121-0649-08 | 61181 | PHARMACEUTICAL ASSOCIATES, INC.DBA PAI |
Technical Data | NSN 6505-01-119-0616
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | BY60.00 MILLIGRAMS CIMETIDINE |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 8.000 FLUID OUNCES |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CIMETIDINE HCL ORAL SOLUTION 60 MG CIMETIDINE PER ML 8 0Z |